USPTO serial 79437487
CARUNZAMO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2026
- Examiner
- HARMON KENNEDY, HEATHER N
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CARUNZAMO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter Sloane
Peter Sloane Leason Ellis LLPOne North Lexington Avenue, Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial, scientific, and diagnostic purposes, namely, chemicals for use in industry and science; chemical diagnostic reagents for industrial and scientific purposes; Biological preparations for use in industry and science; Biological diagnostic preparations for scientific or research use; biochemical preparations for use in industry and science; biochemical diagnostic preparations for scientific or research use; chemical, biological and biochemical products, namely, chemical preparations, biological preparations, and biological preparations for industrial or scientific use in separation processes for biological materials, and not for medical purposes; reagents for cell separation, labeling reagents, reagents, media, substances and ingredients for the preparation of media, namely, chemical reagents for scientific purposes and not for medical purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials, namely, chemical reagents for scientific purposes and not for medical purposes; chemical reagents with magnetic beads for scientific purposes; antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; buffer solutions for use in analytical chemistry and chemical reagents for use with laboratory instruments, separation instruments, analysis instruments, reactors and imaging instruments, all for scientific purposes and not for medical purposes; chemical reagents for processing of biological material, biological tissue, bone marrow, cells, blood and its components for scientific purposes and not for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical research laboratories, other than for medical use; blood culture media, cell culture media, and cell freezing media, all for scientific purposes; chemical reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry, all for scientific or industrial purposes and not for medical purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for treating cancer and autoimmune diseases; medical preparations for the treatment of for treating cancer and autoimmune diseases; veterinary preparations for treating cancer and autoimmune diseases; Chemical reagents for medical or veterinary purposes; media and materials and ingredients for the preparation of media, all for cell cultures for medical or veterinary purposes; Chemical reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of biological materials, all for medical or veterinary purposes; chemical reagents with magnetic beads, and antibody reagents used for the detection of antigens in cells and tissue for medical purposes, all for medical or veterinary purposes; reagents for use with medical instruments, separation instruments, analysis instruments, reactor and imaging instruments, for medical purposes; clinical medical reagents for the processing of biological material, biological tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media for cultivating human cells; cell culture media, diagnostic reagents and preparations, all for medical and veterinary purposes; cell freezing media, X-ray contrast agents, and contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products for cellular therapy | ACTIVE | — |
| 042 | Services of medical research, pharmaceutical production, or biotechnological research laboratories; medical and pharmaceutical services, namely services of a medical research and pharmaceutical production laboratory in the fields of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, and the selection, stimulation, and activation of cells | ACTIVE | — |
| 044 | Medical services in the field of extracorporeal plasma therapy; medical treatment services, namely, medical services for the treatment of cancer or autoimmune diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CARUNZAMO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 9, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 9, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 26, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 19, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |